QC
APLS icon

Quantessence Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Quantessence Capital’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,121
Closed -$206K – 81
2026
Q1 		$206K Buy
+5,121
New +$110K 1% 48

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantessence Capital's APLS Position: Q2 2026 in Review

Quantessence Capital sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 5,121 shares — an estimated $206K sold.

Quantessence Capital first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $206K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Quantessence Capital reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Quantessence Capital sold 5,121 Apellis Pharmaceuticals shares in Q2 2026, an estimated $206K.
  • Quantessence Capital first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Quantessence Capital's Apellis Pharmaceuticals position peaked at $206K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Quantessence Capital's 13F filing for Q2 2026, filed 14 Aug 2026.